awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33410081-4C9D02F7-E527-4167-AA25-B94D6C9C83DE
Q33410081-4C9D02F7-E527-4167-AA25-B94D6C9C83DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410081-4C9D02F7-E527-4167-AA25-B94D6C9C83DE
Brentuximab vedotin: treatment role for relapsed refractory systemic anaplastic large-cell lymphoma.
P2860
Q33410081-4C9D02F7-E527-4167-AA25-B94D6C9C83DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410081-4C9D02F7-E527-4167-AA25-B94D6C9C83DE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
05df9773ab6861cf4b5e0eaf2ecd90cd9ce61ae1
P2860
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.